RAD51D and breast carcinoma: With a panel of 34 putative susceptibility genes, a significant association between the increased risk of breast cancer and truncating mutations in ATM, CHEK2, PALB2, BARD1, RAD51C, RAD51D, and TP53 was identified [27].